Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norditropin Liquid vs Lyophilized in Pediatric GHD
NCT01502124Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2001
- Primary completion
- Mar 2003
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), sponsored by Novo Nordisk. Started May 2001; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01502124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01502124.